Curi RMB Capital LLC Sells 51,150 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Curi RMB Capital LLC reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 91.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,650 shares of the company’s stock after selling 51,150 shares during the period. Curi RMB Capital LLC’s holdings in Henry Schein were worth $339,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HSIC. Cromwell Holdings LLC raised its position in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC purchased a new stake in Henry Schein in the second quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the 2nd quarter valued at approximately $37,000. Blue Trust Inc. raised its position in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HSIC. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird dropped their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Finally, Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $68.76 on Friday. The company has a market capitalization of $8.57 billion, a PE ratio of 28.30, a price-to-earnings-growth ratio of 1.94 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average is $70.30 and its two-hundred day moving average is $69.57.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.32 earnings per share. As a group, analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.